Neoadjuvant versus adjuvant chemotherapy with taxanes and anthracycline-based regimen: Which leads to better outcome in patients with different subtype breast cancer?
Houpu Yang
Disclosure not yet available
Shu Wang
Disclosure not yet available
Lixin Zhou
Disclosure not yet available
Jiajia Guo
Disclosure not yet available
Yingming Cao
Disclosure not yet available
Bo Zhou
Disclosure not yet available
Lin Cheng
Disclosure not yet available
Fei Xie
Disclosure not yet available
Hongjun Liu
Disclosure not yet available
Fuzhong Tong
Disclosure not yet available
Miao Liu
Disclosure not yet available
Peng Liu
Disclosure not yet available
Siyuan Wang
Disclosure not yet available
Deqi Yang
Disclosure not yet available
Jiaqing Zhang
Disclosure not yet available